1. Home
  2. SOPA vs SNOA Comparison

SOPA vs SNOA Comparison

Compare SOPA & SNOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SOPA
  • SNOA
  • Stock Information
  • Founded
  • SOPA 2018
  • SNOA 1999
  • Country
  • SOPA Singapore
  • SNOA United States
  • Employees
  • SOPA N/A
  • SNOA N/A
  • Industry
  • SOPA EDP Services
  • SNOA Biotechnology: Pharmaceutical Preparations
  • Sector
  • SOPA Technology
  • SNOA Health Care
  • Exchange
  • SOPA Nasdaq
  • SNOA Nasdaq
  • Market Cap
  • SOPA 7.3M
  • SNOA 6.5M
  • IPO Year
  • SOPA 2021
  • SNOA 2007
  • Fundamental
  • Price
  • SOPA $2.16
  • SNOA $3.79
  • Analyst Decision
  • SOPA Strong Buy
  • SNOA
  • Analyst Count
  • SOPA 1
  • SNOA 0
  • Target Price
  • SOPA $18.00
  • SNOA N/A
  • AVG Volume (30 Days)
  • SOPA 996.5K
  • SNOA 63.1K
  • Earning Date
  • SOPA 11-13-2025
  • SNOA 11-07-2025
  • Dividend Yield
  • SOPA N/A
  • SNOA N/A
  • EPS Growth
  • SOPA N/A
  • SNOA N/A
  • EPS
  • SOPA N/A
  • SNOA N/A
  • Revenue
  • SOPA $7,522,939.00
  • SNOA $14,912,000.00
  • Revenue This Year
  • SOPA $26.32
  • SNOA $23.00
  • Revenue Next Year
  • SOPA $13.64
  • SNOA $24.59
  • P/E Ratio
  • SOPA N/A
  • SNOA N/A
  • Revenue Growth
  • SOPA 0.31
  • SNOA 17.43
  • 52 Week Low
  • SOPA $0.64
  • SNOA $1.75
  • 52 Week High
  • SOPA $6.75
  • SNOA $6.92
  • Technical
  • Relative Strength Index (RSI)
  • SOPA 45.06
  • SNOA 43.84
  • Support Level
  • SOPA $2.52
  • SNOA $3.73
  • Resistance Level
  • SOPA $3.14
  • SNOA $4.01
  • Average True Range (ATR)
  • SOPA 0.32
  • SNOA 0.20
  • MACD
  • SOPA -0.14
  • SNOA 0.00
  • Stochastic Oscillator
  • SOPA 4.96
  • SNOA 32.35

About SOPA Society Pass Incorporated

Society Pass Inc is building an ecosystem of platforms and technology-enabled companies that synergistically work together to transform how consumers and merchants interact with one another in Southeast Asia and South Asia. Through the acquisition of companies and partnerships with entrepreneurs, the company meets the growing demand for services in sectors such as lifestyle, beauty, travel, and food and beverage. The company currently operates in Six reportable operating segments: Online Grocery and Food deliveries, Digital marketing, Online ticketing and reservation, Telecommunications Reseller, e-commerce, and Corporate. The company generates the majority of its revenue from the Digital marketing segment.

About SNOA Sonoma Pharmaceuticals Inc.

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.

Share on Social Networks: